First Trust Advisors LP reduced its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 45.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 43,516 shares of the medical technology company's stock after selling 36,931 shares during the period. First Trust Advisors LP owned approximately 0.09% of Teleflex worth $7,745,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Norges Bank purchased a new position in shares of Teleflex in the 4th quarter valued at about $100,328,000. Invesco Ltd. grew its position in shares of Teleflex by 48.1% in the 4th quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock valued at $190,188,000 after buying an additional 347,003 shares during the last quarter. Diamond Hill Capital Management Inc. acquired a new stake in Teleflex during the 4th quarter worth $46,696,000. Magnetar Financial LLC lifted its position in Teleflex by 105.2% in the fourth quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company's stock valued at $74,990,000 after acquiring an additional 215,961 shares during the last quarter. Finally, Cooke & Bieler LP boosted its stake in Teleflex by 22.1% in the fourth quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company's stock valued at $191,962,000 after acquiring an additional 195,150 shares in the last quarter. Hedge funds and other institutional investors own 95.62% of the company's stock.
Teleflex Stock Performance
NYSE:TFX traded up $0.43 during mid-day trading on Friday, hitting $126.30. The stock had a trading volume of 753,291 shares, compared to its average volume of 638,142. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a 50 day simple moving average of $135.82 and a 200-day simple moving average of $170.78. The stock has a market capitalization of $5.86 billion, a price-to-earnings ratio of 25.11, a P/E/G ratio of 1.73 and a beta of 1.19. Teleflex Incorporated has a 52 week low of $124.66 and a 52 week high of $249.91.
Teleflex (NYSE:TFX - Get Free Report) last announced its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $700.67 million during the quarter, compared to analyst estimates of $699.37 million. During the same quarter in the prior year, the firm posted $3.21 EPS. Teleflex's revenue was down 5.0% compared to the same quarter last year. On average, research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.08%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex's payout ratio is currently 95.77%.
Wall Street Analyst Weigh In
TFX has been the topic of a number of research analyst reports. Wells Fargo & Company cut their target price on Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a research report on Friday. Needham & Company LLC reissued a "hold" rating on shares of Teleflex in a report on Wednesday, March 12th. StockNews.com cut shares of Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Morgan Stanley decreased their price target on shares of Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a research note on Wednesday, March 5th. Finally, Bank of America lowered shares of Teleflex from a "neutral" rating to an "underperform" rating and dropped their price objective for the company from $235.00 to $140.00 in a research note on Tuesday, March 4th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $167.25.
Read Our Latest Stock Analysis on Teleflex
About Teleflex
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Further Reading
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
